Again Acquires Genomatica to Enhance Biotech Capabilities
Again has acquired Genomatica, enhancing its capabilities in the industrial biotechnology sector. This acquisition allows Again to leverage Genomatica's extensive intellectual property and process development experience, which could accelerate its market entry and technology development in renewable feedstocks.
Theia Market Signal Identification - AI Assisted
Again has completed the acquisition of Genomatica, a move aimed at strengthening its position in industrial biotechnology. Terms of the transaction remain undisclosed. Established in 2021, Again utilizes engineered microbes for converting carbon dioxide and hydrogen into chemicals, with a production facility in Texas operational since 2025.
Genomatica, founded earlier, brings extensive intellectual property and process development experience, including successful commercial deployments like its BDO technology at a Novamont plant in Italy and a $360 million plant in Iowa. The acquisition positions Again to explore licensing technologies, co-developing production pathways, and leveraging Genomatica's data for faster process development. There are potential implications for the industry, as this merger may enhance competition and innovation in the renewable chemicals market.
Comments